| Dr Matthew T Robinson, MD | |
|
One Hospital Drive, Columbia, MO 65212-0001 | |
| (573) 882-8091 | |
| (573) 884-1902 |
| Full Name | Dr Matthew T Robinson |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 26 Years |
| Location | One Hospital Drive, Columbia, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407829187 | NPI | - | NPPES |
| 204021109 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 2000146141 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Missouri Health Care | Columbia, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Curators Of The University Of Missouri | 4486759560 | 959 |
News Archive
3Pea International Inc., a payment solutions company, today announced that it has filed a registration statement on Form 10 with the Securities and Exchange Commission (SEC) to register its common stock pursuant to Section 12(g) of the Securities Exchange Act of 1934.
Neura Therapeutik announced today that they will be accelerating the development of their abuse-deterrent brand and generic extended-release opioids.
ATLAB Pharma SAS and BZL Biologics LLC have entered into a sublicense agreement to develop 177Lu-J591 for cancer treatment. It includes exclusive rights to manufacture, develop and commercialize this radiopharmaceutical product worldwide as well as a joint Phase IIB/III clinical validation program.
24 Hour Data today announced its support for Breast Cancer Awareness Month. In an effort to raise awareness about the importance of early detection of breast cancer, the Dallas-based company will donate 5% of its October sales to the National Breast Cancer Foundation, Inc. (NBCF).
Researchers at the Rabin Medical Center in Israel have determined that the use of drug-eluting stents (DES) improves the long-term clinical outcome for patients undergoing percutaneous coronary intervention (PCI), commonly known as angioplasty. Results of this study appear in the September issue of Catheterization and Cardiovascular Interventions, a journal published by Wiley-Blackwell on behalf of The Society for Cardiovascular Angiography and Interventions.
› Verified 3 days ago
| Entity Name | The Curators Of The University Of Missouri |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235126921 PECOS PAC ID: 4486759560 Enrollment ID: O20070418000290 |
News Archive
3Pea International Inc., a payment solutions company, today announced that it has filed a registration statement on Form 10 with the Securities and Exchange Commission (SEC) to register its common stock pursuant to Section 12(g) of the Securities Exchange Act of 1934.
Neura Therapeutik announced today that they will be accelerating the development of their abuse-deterrent brand and generic extended-release opioids.
ATLAB Pharma SAS and BZL Biologics LLC have entered into a sublicense agreement to develop 177Lu-J591 for cancer treatment. It includes exclusive rights to manufacture, develop and commercialize this radiopharmaceutical product worldwide as well as a joint Phase IIB/III clinical validation program.
24 Hour Data today announced its support for Breast Cancer Awareness Month. In an effort to raise awareness about the importance of early detection of breast cancer, the Dallas-based company will donate 5% of its October sales to the National Breast Cancer Foundation, Inc. (NBCF).
Researchers at the Rabin Medical Center in Israel have determined that the use of drug-eluting stents (DES) improves the long-term clinical outcome for patients undergoing percutaneous coronary intervention (PCI), commonly known as angioplasty. Results of this study appear in the September issue of Catheterization and Cardiovascular Interventions, a journal published by Wiley-Blackwell on behalf of The Society for Cardiovascular Angiography and Interventions.
› Verified 3 days ago
| Entity Name | Ripley Emergency Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720606023 PECOS PAC ID: 1254757446 Enrollment ID: O20200819000175 |
News Archive
3Pea International Inc., a payment solutions company, today announced that it has filed a registration statement on Form 10 with the Securities and Exchange Commission (SEC) to register its common stock pursuant to Section 12(g) of the Securities Exchange Act of 1934.
Neura Therapeutik announced today that they will be accelerating the development of their abuse-deterrent brand and generic extended-release opioids.
ATLAB Pharma SAS and BZL Biologics LLC have entered into a sublicense agreement to develop 177Lu-J591 for cancer treatment. It includes exclusive rights to manufacture, develop and commercialize this radiopharmaceutical product worldwide as well as a joint Phase IIB/III clinical validation program.
24 Hour Data today announced its support for Breast Cancer Awareness Month. In an effort to raise awareness about the importance of early detection of breast cancer, the Dallas-based company will donate 5% of its October sales to the National Breast Cancer Foundation, Inc. (NBCF).
Researchers at the Rabin Medical Center in Israel have determined that the use of drug-eluting stents (DES) improves the long-term clinical outcome for patients undergoing percutaneous coronary intervention (PCI), commonly known as angioplasty. Results of this study appear in the September issue of Catheterization and Cardiovascular Interventions, a journal published by Wiley-Blackwell on behalf of The Society for Cardiovascular Angiography and Interventions.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Matthew T Robinson, MD Po Box 843966, Kansas City, MO 64184-3966 Ph: (573) 884-3300 | Dr Matthew T Robinson, MD One Hospital Drive, Columbia, MO 65212-0001 Ph: (573) 882-8091 |
News Archive
3Pea International Inc., a payment solutions company, today announced that it has filed a registration statement on Form 10 with the Securities and Exchange Commission (SEC) to register its common stock pursuant to Section 12(g) of the Securities Exchange Act of 1934.
Neura Therapeutik announced today that they will be accelerating the development of their abuse-deterrent brand and generic extended-release opioids.
ATLAB Pharma SAS and BZL Biologics LLC have entered into a sublicense agreement to develop 177Lu-J591 for cancer treatment. It includes exclusive rights to manufacture, develop and commercialize this radiopharmaceutical product worldwide as well as a joint Phase IIB/III clinical validation program.
24 Hour Data today announced its support for Breast Cancer Awareness Month. In an effort to raise awareness about the importance of early detection of breast cancer, the Dallas-based company will donate 5% of its October sales to the National Breast Cancer Foundation, Inc. (NBCF).
Researchers at the Rabin Medical Center in Israel have determined that the use of drug-eluting stents (DES) improves the long-term clinical outcome for patients undergoing percutaneous coronary intervention (PCI), commonly known as angioplasty. Results of this study appear in the September issue of Catheterization and Cardiovascular Interventions, a journal published by Wiley-Blackwell on behalf of The Society for Cardiovascular Angiography and Interventions.
› Verified 3 days ago
Rylee Shawn Duckworth, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Dr, Columbia, MO 65212 Phone: 573-884-4400 Fax: 573-884-5994 | |
Dr. Michael Habhab, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Hospital Dr Emergency Medicine M562 Dc029.10, Columbia, MO 65212 Phone: 573-884-4400 | |
Michael Hauan, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1600 E Broadway, Columbia, MO 65201 Phone: 573-815-3573 Fax: 314-631-4491 | |
Derek G Hebert, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Dr, Columbia, MO 65212 Phone: 573-882-6003 Fax: 573-884-5410 | |
Dr. Betsy Lynn Borsheski, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Dr, Columbia, MO 65212 Phone: 573-882-8091 Fax: 573-884-1902 | |
Dylan Carroll, Emergency Medicine Medicare: Medicare Enrolled Practice Location: One Hospital Drive, Suite M562, Columbia, MO 65212 Phone: 573-884-3233 Fax: 573-884-5994 | |
Beth Kreutzer, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Hospital Dr # Dc029.10, Columbia, MO 65212 Phone: 573-884-3233 |